Pharmacotherapy of focal epilepsy in children: A systematic review of approved agents

CNS Drugs

Volumn 27, Issue 4, 2013, Pages 273-286

  Arya, Ravindra ^a   Glauser, Tracy A ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PRIMIDONE; STIRIPENTOL; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABDOMINAL PAIN; ACUTE CEREBELLAR SYNDROME; AGGRESSION; ANOREXIA; ASTHENIA; ATAXIA; BLEEDING; BRONCHOSPASM; CEREBELLUM DISEASE; COMPLEX PARTIAL SEIZURE; COUGHING; DIARRHEA; DIPLOPIA; DIZZINESS; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EPILEPSY; FATIGUE; FEVER; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GENERALIZED TONIC CLONIC SEIZURE; GINGIVA HYPERPLASIA; HEADACHE; HOSTILITY; HUMAN; HYPERTRICHOSIS; IRRITABILITY; LENNOX GASTAUT SYNDROME; LOW DRUG DOSE; MEDLINE; MENTAL INSTABILITY; MIXED SEIZURE; MONOTHERAPY; MOOD DISORDER; MYOCLONUS SEIZURE; NAUSEA; NAUSEA AND VOMITING; NERVOUSNESS; NYSTAGMUS; OUTCOME ASSESSMENT; PRIMARY GENERALIZED TONIC CLONIC SEIZURE; PRIORITY JOURNAL; PURPURA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SALIVATION; SEIZURE; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SIDE EFFECT; SKIN DISEASE; SOMNOLENCE; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; TREMOR; UNSPECIFIED SIDE EFFECT; VIRUS INFECTION; VOMITING; WEIGHT REDUCTION; WEST SYNDROME; XEROSTOMIA;

ANTICONVULSANTS; CHILD; DECISION MAKING; DRUG APPROVAL; EPILEPSIES, PARTIAL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 84878253758     PISSN: 11727047     EISSN: 11791934     Source Type: Journal    
DOI: 10.1007/s40263-013-0048-z     Document Type: Review

References (57)

1. Banerjee PN, Hauser WA. Incidence and prevalence In: Engel Jr. J, Pedley TA, editors. Epilepsy: A comprehensive textbook. Philadelphia: Wolters Kluwer; 2008. p. 45-57.
2. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia. 1989;30(4):389-99.
3. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, et al. ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2006;47(7):1094-120.
4. Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Guerreiro C, Kälviäinen R, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013. [Epub ahead of print]
5. French JA, Kanner AM, Bautista J, Abou-Khalil B, Browne T, Harden CL, et al. Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: Report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. 2004;45(5):410-23.
6. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, et al. Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. 2010;51(4):676-85.
7. Wheless JW, Neto W, Wang S. Topiramate, carbamazepine, and valproate monotherapy: Double-blind comparison in children with newly diagnosed epilepsy. J Child Neurol. 2004;19(2):135-41.
8. Koch MW, Polman SK. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures. Cochrane Database Syst Rev. 2009(4):CD006453.
9. Bittencourt PR, Antoniuk SA, Bigarella MM, da Costa JC, Doro MP, Ferreira AS, et al. Carbamazepine and phenytoin in epilepsies refractory to barbiturates: Efficacy, toxicity and mental function. Epilepsy Res. 1993;16(2):147-55.
10. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. Epilepsia. 1998;39(9):952-9.
11. Bourgeois B, Brown LW, Pellock JM, Buroker M, Greiner M, Garofalo EA, et al. Gabapentin (Neurontin) monotherapy in children with Benign Childhood Epilepsy with centrotemporal spikes (BECTS): A 36-week, double-blind, placebo-controlled study. Epilepsia. 1998;39(s6):163.
12. Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, et al. Gabapentin as add-on therapy in children with refractory partial seizures: A 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Epilepsia. 1999;40(8):1147-54.
13. Nieto-Barrera M, Brozmanova M, Capovilla G, Christe W, Pedersen B, Kane K, et al. A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res. 2001;46(2):145-55.
14. Gamble CL, Williamson PR, Marson AG. Lamotrigine versus carbamazepine monotherapy for epilepsy. Cochrane Database Syst Rev. 2006(1):CD001031.
15. Gamble C, Williamson PR, Chadwick DW, Marson AG. A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy. Neurology. 2006;66(9):1310-7.
16. Duchowny M, Pellock JM, Graf WD, Billard C, Gilman J, Casale E, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology. 1999;53(8):1724-31.
17. Pina-Garza JE, Levisohn P, Gucuyener K, Mikati MA, Warnock CR, Conklin HS, et al. Adjunctive lamotrigine for partial seizures in patients aged 1 to 24 months. Neurology. 2008;70(22 Pt 2):2099-108.
18. Pina-Garza JE, Elterman RD, Ayala R, Corral M, Mikati MA, Pina-Garza MJ, et al. Long-term tolerability and efficacy of lamotrigine in infants 1 to 24 months old. J Child Neurol. 2008;23(8):853-61.
19. Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology. 2006;66(11):1654-60.
20. Pina-Garza JE, Nordli DR Jr, Rating D, Yang H, Schiemann-Delgado J, Duncan B. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia. 2009;50(5):1141-9.
21. Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res. 1997;27(3):205-13.
22. Novartis-Pharmaceutical. Trileptal prescribing information. East Hanover, NJ, 2004.
23. Muller M, Marson AG, Williamson PR. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Cochrane Database Syst Rev. 2006(2):CD003615.
24. Glauser TA, Nigro M, Sachdeo R, Pasteris LA, Weinstein S, Abou-Khalil B, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology. 2000;54(12):2237-44.
25. Pina-Garza JE, Espinoza R, Nordli D, Bennett DA, Spirito S, Stites TE, et al. Oxcarbazepine adjunctive therapy in infants and young children with partial seizures. Neurology. 2005;65(9):1370-5.
26. Sommerfeld-Ziskin E. The effect of phenobarbital on the mentality of epileptic patients. Arch Neurol Psychiatry. 1940;43:70-9.
27. Pal DK, Das T, Chaudhury G, Johnson AL, Neville BG. Randomised controlled trial to assess acceptability of phenobarbital for childhood epilepsy in rural India. Lancet. 1998;351(9095):19-23.
28. Mitchell WG, Chavez JM. Carbamazepine versus phenobarbital for partial onset seizures in children. Epilepsia. 1987;28(1):56-60.
29. Chiron C, Tonnelier S, Rey E, Brunet ML, Tran A, d'Athis P, et al. Stiripentol in childhood partial epilepsy: Randomized placebo-controlled trial with enrichment and withdrawal design. J Child Neurol. 2006;21(6):496-502.
30. Gilliam FG, Veloso F, Bomhof MA, Gazda SK, Biton V, Ter Bruggen JP, et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology. 2003;60(2):196-202.
31. Glauser TA, Dlugos DJ, Dodson WE, Grinspan A, Wang S, Wu SC. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents. J Child Neurol. 2007;22(6):693-9.
32. Elterman RD, Glauser TA, Wyllie E, Reife R, Wu SC, Pledger G. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology. 1999;52(7):1338-44.
33. Novotny E, Renfroe B, Yardi N, Nordli D, Ness S, Wang S, et al. Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures. Neurology. 2010;74(9):714-20.
34. Loiseau P, Cohadon S, Jogeix M, Legroux M, Dartigues JF. Efficacy of sodium valproate in partial epilepsy. Crossed study of valproate and carbamazepine. Rev Neurol (Paris). 1984;140(6-7):434-7.
35. Verity CM, Hosking G, Easter DJ. A multicentre comparative trial of sodium valproate and carbamazepine in paediatric epilepsy. The Paediatric EPITEG Collaborative Group. Dev Med Child Neurol. 1995;37(2):97-108.
36. Shakir RA, Johnson RH, Lambie DG, Melville ID, Nanda RN. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy. Epilepsia. 1981;22(1):27-33.
37. Rastogi P, Mehrotra TN, Agarwala RK, Singh VS. Comparison of sodium valproate and phenytoin as single drug treatment in generalised and partial epilepsy. J Assoc Phys India. 1991;39(8):606-8.
38. Callaghan N, Kenny RA, O'Neill B, Crowley M, Goggin T. A prospective study between carbamazepine, phenytoin and sodium valproate as monotherapy in previously untreated and recently diagnosed patients with epilepsy. J Neurol Neurosurg Psychiatry. 1985;48(7):639-44.
39. de Silva M, MacArdle B, McGowan M, Hughes E, Stewart J, Neville BG, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. Lancet. 1996;347(9003):709-13.
40. Zamponi N, Cardinali C. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. Arch Neurol. 1999;56(5):605-7.
41. Sobaniec W, Kulak W, Strzelecka J, Smigielska-Kuzia J, Bockowski L. A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children. Pharmacol Rep. 2005;57(5):646-53.
42. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet. 1999;354(9172):13-9.
43. Eun SH, Kim HD, Eun BL, Lee IK, Chung HJ, Kim JS, et al. Comparative trial of low- and high-dose zonisamide as monotherapy for childhood epilepsy. Seizure. 2011;20(7):558-63.
44. Arroyo S, Boothman BR, Brodie MJ, Duncan JS, Duncan R, Nieto M, et al. A randomised open-label study of tiagabine given two or three times daily in refractory epilepsy. Seizure. 2005;14(2):81-4.
45. Jedrzejczak J. Tiagabine as add-on therapy may be more effective with valproic acid-open label, multicentre study of patients with focal epilepsy. Eur J Neurol. 2005;12(3):176-80.
46. Uthman BM, Rowan AJ, Ahmann PA, Leppik IE, Schachter SC, Sommerville KW, et al. Tiagabine for complex partial seizures: A randomized, add-on, dose-response trial. Arch Neurol. 1998;55(1):56-62.
47. Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985;313(3):145-51.
48. Faught E, Sachdeo RC, Remler MP, Chayasirisobhon S, Iragui-Madoz VJ, Ramsay RE, et al. Felbamate monotherapy for partial-onset seizures: An active-control trial. Neurology. 1993;43(4):688-92.
49. Bourgeois B, Leppik IE, Sackellares JC, Laxer K, Lesser R, Messenheimer JA, et al. Felbamate: A double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Neurology. 1993;43(4):693-6.
50. Sachdeo R, Kramer LD, Rosenberg A, Sachdeo S. Felbamate monotherapy: Controlled trial in patients with partial onset seizures. Ann Neurol. 1992;32(3):386-92.
51. Canger R, Vignoli A, Bonardi R, Guidolin L. Felbamate in refractory partial epilepsy. Epilepsy Res. 1999;34(1):43-8.
52. Avanzini G, Canger R, Dalla Bernardina B, Vigevano F. Felbamate in therapy-resistant epilepsy: An Italian experience. Felbamate Italian Study Group. Epilepsy Res. 1996;25(3):249-55.
53. Faught E. Antiepileptic drug trials: The view from the clinic. Epileptic Disord. 2012;14(2):114-23.
54. Beghi E, Gatti G, Tonini C, Ben-Menachem E, Chadwick DW, Nikanorova M, et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: A multicentre, randomised, pragmatic controlled trial. Epilepsy Res. 2003;57(1):1-13.
55. Nordli DR Jr, Bazil CW, Scheuer ML, Pedley TA. Recognition and classification of seizures in infants. Epilepsia. 1997;38(5):553-60.
56. Nordli DR Jr, Kuroda MM, Hirsch LJ. The ontogeny of partial seizures in infants and young children. Epilepsia. 2001;42(8):986-90.
57. Garofalo E. Obtaining pediatric indications for new anti-epileptic drugs: How and when. Epilepsy Res. 2006;68(1):38-42.